Immunogenicity and safety of a booster vaccination with a recombinant protein RBD fusion dimer candidate (PHH-1V) againts SARS-COV-2 in adults fully vaccinated againts COVID-19
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.